OptimizeRx Corporation(OPRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

OPRX OptimizeRx Corporation

Post-Mkt 08-31 19:42:16 EDT

7.98

+0.03

+0.38%

盘后7.72

-0.26-3.26%

19:30 EDT

High8.04	Low7.71	Vol170.85K
Open7.89	D1 Closing7.95	Amplitude4.17%
Mkt Cap149.70M	Tradable Cap115.69M	Total Shares18.76M
T/O1.36M	T/O Rate1.18%	Tradable Shares14.50M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"OPRX","market":"US","secType":"STK","nameCN":"OptimizeRx Corporation","latestPrice":7.98,"timestamp":1788206400000,"preClose":7.95,"halted":0,"volume":170854,"hourTrading":{"tag":"盘后","latestPrice":7.72,"preClose":7.98,"latestTime":"19:30 EDT","volume":3244,"amount":25572.6511816,"timestamp":1788219002390,"change":-0.26,"changeRate":-0.032581,"amplitude":0.036341},"delay":0,"changeRate":0.0037735849056604086,"floatShares":14497600,"shares":18759600,"eps":0.246086,"marketStatus":"Post-Mkt","change":0.03,"latestTime":"08-31 19:42:16 EDT","open":7.89,"high":8.04,"low":7.7086,"amount":1357260.246358,"amplitude":0.041686,"askPrice":9.44,"askSize":100,"bidPrice":6.92,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.246086,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":7.95,"preHourTrading":{"tag":"盘前","latestPrice":7.99,"preClose":7.95,"latestTime":"08:40 EDT","volume":236,"amount":1849.66003,"timestamp":1788180037299,"change":0.04,"changeRate":0.005031,"amplitude":0.062893},"postHourTrading":{"tag":"盘后","latestPrice":7.72,"preClose":7.98,"latestTime":"19:30 EDT","volume":3244,"amount":25572.6511816,"timestamp":1788219002390,"change":-0.26,"changeRate":-0.032581,"amplitude":0.036341},"volumeRatio":0.853794,"impliedVol":0.6066,"impliedVolPercentile":0.1235},"requestUrl":"/m/hq/s/OPRX/wiki","defaultTab":"wiki","newsList":[{"id":"2660830154","title":"OptimizeRx names Andy D’Silva CFO, Heather Favazza chief accounting officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660830154","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660830154?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:43","pubTimestamp":1786956187,"startTime":"0","endTime":"0","summary":"OptimizeRx (OPRX) announced the company’s board of directors has appointed Andy D’Silva to succeed Ed Stelmakh as CFO, effective January 1, 2027. T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimizerx-names-andy-dsilva-cfo-heather-favazza-chief-accounting-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimizerx-names-andy-dsilva-cfo-heather-favazza-chief-accounting-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","OPRX","CFO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144982","title":"OptimizeRx is Maintained at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144982?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:08","pubTimestamp":1786712880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OPRX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659519358","title":"Marpai Q2 Revenue Falls Due to Turnover and Continued Customer Pruning","url":"https://stock-news.laohu8.com/highlight/detail?id=2659519358","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659519358?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:58","pubTimestamp":1786658300,"startTime":"0","endTime":"0","summary":"Marpai Q2 revenue falls due to turnover and continued customer pruningOverviewUS healthcare technology firm's Q2 revenue fell 10.5% yr/yr due to customer turnover and pruningGross margin improved to 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A1C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","HCTI","MRAI","BK4082","OPRX","DRIO","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659150134","title":"Lake Street Sticks to Their Buy Rating for OptimizeRx (OPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659150134","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659150134?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:37","pubTimestamp":1786628262,"startTime":"0","endTime":"0","summary":"Lake Street analyst Eric Martinuzzi maintained a Buy rating on OptimizeRx today and set a price target of $11.00. According to TipRanks, Martinuzzi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-their-buy-rating-for-optimizerx-oprx-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-their-buy-rating-for-optimizerx-oprx-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151392","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151392","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151392?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:40","pubTimestamp":1786621235,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on OptimizeRx (OPRX) and RenovoRx (RNXT) with bullish s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-298?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-298?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","RNXT","BK4139","BK4539","OPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659884185","title":"Optimizerx Announces Finance Leadership Appointments to Support the Next Phase of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659884185","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659884185?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:33","pubTimestamp":1786570414,"startTime":"0","endTime":"0","summary":"Aug 12 (Reuters) - OptimizeRx Corporation::*OPTIMIZERX ANNOUNCES FINANCE LEADERSHIP APPOINTMENTS TO  SUPPORT THE NEXT PHASE OF GROWTH*OPTIMIZERX CORPORATION - APPOINTS ANDY D’SILVA AS CFO AND HEATHER ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nRSD7FRrqc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","OPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659183880","title":"OptimizeRx Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659183880","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659183880?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:01","pubTimestamp":1786568506,"startTime":"0","endTime":"0","summary":"OptimizeRx Corporation reports results for the quarter ended June 30 - Earnings SummaryOptimizeRx CorporationOPRX.OQreported quarterly adjusted earnings of 16 cents per share for the quarter ended Jun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N44926G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188912","title":"OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188912?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:29","pubTimestamp":1786566596,"startTime":"0","endTime":"0","summary":"OptimizeRx ( ($OPRX) ) has provided an update. OptimizeRx Corp. announced on August 7, 2026, that Chief Financial & Strategy Officer Edward Stelmak...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optimizerx-reaffirms-2026-outlook-amid-revenue-decline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optimizerx-reaffirms-2026-outlook-amid-revenue-decline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPRX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659390086","title":"OptimizeRx Names Andy D'Silva CFO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2659390086","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659390086?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:11","pubTimestamp":1786565494,"startTime":"0","endTime":"0","summary":"OptimizeRx names Andy D'Silva CFO effective Jan. 1, 2027OptimizeRx named Andy D'Silva chief financial officer, effective Jan. 1, 2027, succeeding Ed Stelmakh.D'Silva previously served as chief busines","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL3w4j1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","BCDF","LU2210149790.SGD","NDAQ","BK4588","OPRX","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4585","BK4112","IE00BKPKM429.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4167","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659043907","title":"OptimizeRx Q2 Revenue Beats Estimates on Operating Resilience; Reaffirms Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659043907","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659043907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:10","pubTimestamp":1786565454,"startTime":"0","endTime":"0","summary":"OptimizeRx Q2 revenue beats estimates on operating resilience; reaffirms outlookOverviewUS healthcare tech firm's Q2 revenue fell 30% yr/yr but beat analyst expectationsQ2 adjusted EBITDA and non-GAAP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44910E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSP","BK4023","OPRX","BK4167","DH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900885","title":"OptimizeRx Q2 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $20.504M Beat $20.204M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900885","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900885?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:10","pubTimestamp":1786565419,"startTime":"0","endTime":"0","summary":"OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.12 by 33.33 percent. This is a 33.33 percent decrease over earnings of $0.24 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61158326/optimizerx-q2-adj-eps-0-16-beats-0-12-estimate-sales-20-504m-beat-20-204m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"OptimizeRx Q2 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $20.504M Beat $20.204M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","OPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907991","title":"OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907991","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907991?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA7H8FLL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OPRX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659475907","title":"OptimizeRx Corporation - Appoints Andy D’silva as CFO and Heather Favazza as Chief Accounting Officer Effective Jan 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2659475907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659475907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565103,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA7H8FLL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OPRX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659076929","title":"OptimizeRx Q2 GAAP Net Loss Narrows to $0.7 Million; Revenue Drops 30% to $20.5 Million Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659076929","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659076929?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:03","pubTimestamp":1786564993,"startTime":"0","endTime":"0","summary":"OptimizeRx Q2 GAAP net loss narrows to $0.7 million; revenue drops 30% to $20.5 million year over yearOptimizeRx Q2 2026 revenue fell 30% to USD 20.5 million year over year.GAAP results swung to a net","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7pmw12:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4588","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","BK4167","SG9999014013.SGD","SG9999014021.USD","BK4112","OPRX","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD","NDAQ","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907689","title":"OPTIMIZERx Q2 Revenue USD 20.5 Million Vs. IBES Estimate USD 20.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907689","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907689?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:02","pubTimestamp":1786564921,"startTime":"0","endTime":"0","summary":"BRIEF-OPTIMIZERx Q2 Revenue USD 20.5 Million Vs. IBES Estimate USD 20.2 MillionAug 12 (Reuters) - OPTIMIZERx Q2 adjusted EBITDA USD 4.9 million vs. IBES estimate USD 2.39 million.Q2 adjusted net income USD 3.1 million vs. IBES estimate USD 1.95 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLX0JJ6MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","OPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907668","title":"OptimizeRx Outlook FY Adjusted Ebitda USD 21-25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907668?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:01","pubTimestamp":1786564861,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLX0JJ6MM:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","OPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658545409","title":"OptimizeRx Corporation Expected to Post Earnings of 12 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658545409","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658545409?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:57","pubTimestamp":1786395426,"startTime":"0","endTime":"0","summary":"OptimizeRx Corporation <OPRX.OQ> expected to post earnings of12cents a share - Earnings PreviewOptimizeRx CorporationOPRX.OQOPRX.Ois expected to  show a fall in quarterly revenue when it reports  resu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N4471YQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","OPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655862458","title":"OptimizeRx Schedules Q2 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655862458","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655862458?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:30","pubTimestamp":1785324654,"startTime":"0","endTime":"0","summary":"OptimizeRx schedules Q2 earnings conference callOptimizeRx will hold a Q2 2026 results conference call on Aug. 12, 2026 at 4:30 p.m. ET.Results for the quarter ended June 30, 2026 will be released bef","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL4GR8k5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4167","BCDF","OPRX","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4112","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653742341","title":"Optimizerx Appoints Sarah Bast as Chief Marketing Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2653742341","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653742341?lang=en_us&edition=fundamental","pubTime":"2026-07-23 19:30","pubTimestamp":1784806250,"startTime":"0","endTime":"0","summary":"OptimizeRx appoints Sarah Bast as chief marketing officerOptimizeRx named Sarah Bast chief marketing officer, tasking her with marketing strategy, brand positioning, go-to-market execution, and agency","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL4Gm2Hm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","BK4585","OPRX","IE00BN0W2T93.GBP","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","BK4588","IE00B64PRP62.GBP","BK4167","SG9999014021.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648566911","title":"Optimizerx Publishes Corporate Presentation on Ai-enabled Platform for Pharma-hcp-patient Engagement","url":"https://stock-news.laohu8.com/highlight/detail?id=2648566911","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648566911?lang=en_us&edition=fundamental","pubTime":"2026-07-01 02:30","pubTimestamp":1782844248,"startTime":"0","endTime":"0","summary":"OptimizeRx publishes corporate presentation on AI-enabled platform for pharma-HCP-patient engagementOptimizeRx outlined fiscal 2026 guidance for revenue of $95 million-$100 million, adjusted EBITDA of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL2YsbLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","OPRX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.optimizerx.com","stockEarnings":[{"period":"1week","weight":0.0311},{"period":"1month","weight":0.248},{"period":"3month","weight":0.5318},{"period":"6month","weight":0.0488},{"period":"1year","weight":-0.5639},{"period":"ytd","weight":-0.3515}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.043426},{"month":2,"riseRate":0.5,"avgChangeRate":-0.003414},{"month":3,"riseRate":0.25,"avgChangeRate":-0.024049},{"month":4,"riseRate":0.5,"avgChangeRate":-0.049925},{"month":5,"riseRate":0.5,"avgChangeRate":0.094804},{"month":6,"riseRate":0.875,"avgChangeRate":0.073964},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.023287},{"month":8,"riseRate":0.666667,"avgChangeRate":0.084572},{"month":9,"riseRate":0.5,"avgChangeRate":0.066303},{"month":10,"riseRate":0.375,"avgChangeRate":-0.045261},{"month":11,"riseRate":0.5,"avgChangeRate":0.019799},{"month":12,"riseRate":0.25,"avgChangeRate":-0.029069}],"exchange":"NASDAQ","name":"OptimizeRx Corporation","nameEN":"OptimizeRx Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"OptimizeRx Corporation(OPRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest OptimizeRx Corporation(OPRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"OptimizeRx Corporation,OPRX,OptimizeRx Corporation股票,OptimizeRx Corporation股票老虎,OptimizeRx Corporation股票老虎国际,OptimizeRx Corporation行情,OptimizeRx Corporation股票行情,OptimizeRx Corporation股价,OptimizeRx Corporation股市,OptimizeRx Corporation股票价格,OptimizeRx Corporation股票交易,OptimizeRx Corporation股票购买,OptimizeRx Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"OptimizeRx Corporation(OPRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest OptimizeRx Corporation(OPRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}